https://european-biotechnology.net/wp-content/uploads/2025/03/Hummingbird-2.png9441000Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-04 09:30:182025-03-04 09:30:18ADC maker Callio Therapeutics secures US$187m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/02/Friedrich-Merz-1030x484-1.jpg4841030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-02-24 10:15:282025-02-24 10:15:28New German Chancellor wants a strong Europe
https://european-biotechnology.net/wp-content/uploads/2025/02/EG-427-nHSV-vectors-1030x404-1.png4041030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-02-20 06:10:162025-02-20 11:32:01French EG 427 bags €27m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2025/02/Catumaxomab_mechanism.svg_-1030x467-1.png4671030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-02-19 14:25:582025-02-19 14:25:58Lindis Biotech selects Celonic Group for commercial manufacturing of catumaxomab
